Tagra Biotechnologies, since its inception in 1998, focuses on the development and manufacturing of microencapsulated ingredients such as vitamins, oils, sunscreen agents, pigments, and others.

Tagra is the first company to patent a unique innovative Release on Demand™ (RND™) Microencapsulation Technology. Tagra’s platform addresses industry challenges of stability, efficiency, and compatibility with other cosmetic and pharmaceutical formulation ingredients.

The technology enables the masking, protection, and release of more than 40 actives and pigments widely used in cosmetics and OTC preparations. Tagra’s microcapsules are friction released through consumer application.

Tagra also owns and operates its own plant and state-of-the-art laboratory meeting all required regulations.